Organizations Filed Purposes:
NASTAD'S MISSION IS TO END THE INTERSECTING EPIDEMICS OF HIV, VIRAL HEPATITIS, AND RELATED CONDITIONS BY STRENGTHENING DOMESTIC AND GLOBAL GOVERNMENTAL PUBLIC HEALTH THROUGH ADVOCACY, CAPACITY BUILDING, AND SOCIAL JUSTICE.
SEE PART III, LINE 1.
PREVENTION: NASTAD HAS A PREVENTION AND SURVEILLANCE PROGRAM FUNDED LARGELY THROUGH TWO CDC COOPERATIVE AGREEMENTS TO CONDUCT CAPACITY BUILDING/TA ACTIVITIES AND COMMUNICATION IN SUPPORT OF STATE AND LOCAL HIV PREVENTION PROGRAMS. CAPACITY BUILDING ACTIVITIES FOCUS ON: 1) INCREASING CAPACITY OF HEALTH DEPARTMENTS IN THE AREAS OF HIV TESTING, PREVENTION WITH POSITIVE INDIVIDUAL'S DATA-TO-CARE ACTIVITIES AND POLICY DEVELOPMENT; AND 2) PROVIDING TECHNICAL ASSISTANCE TO HEALTH DEPARTMENTS AND CDC-DIRECTLY FUNDED COMMUNITY BASED ORGANIZATIONS (CBOS) ON INTEGRATED HIV PREVENTION STRATEGIES. TA ACTIVITIES INCLUDE IMPLEMENTATION OF PREVENTION STRATEGIES; COMMUNICATIONS WITH AND TA FOR HEALTH DEPARTMENTS; OPERATION OF A PEER TA NETWORK, THE PREVENTION NETWORKING GROUP (PNG); AND PERIODIC ASSESSMENT OF HIV PREVENTION PROGRAMS. NASTAD'S WORK ALSO INCLUDES TA IN THE AREAS OF EFFECTIVE HIGH-IMPACT HIV PREVENTION INTERVENTIONS; HIV PREVENTION FOR GAY MEN OF ALL RACES AND ETHNICITIES; HIV PREVENTION FOR PERSONS WHO INJECT DRUGS; HIV SURVEILLANCE; SOCIAL MARKETING; RAPID AND OTHER HIV TESTING; INTEGRATION OF HIV, VIRAL HEPATITIS, STD AND TUBERCULOSIS PROGRAMS; AND PREVENTION OF PERINATAL HIV TRANSMISSION.
HEALTH CARE ACCESS: NASTAD HAS A COOPERATIVE AGREEMENT WITH HEALTH RESOURCES AND SERVICE ADMINISTRATION (HRSA) TO PROVIDE TECHNICAL ASSISTANCE (TA) FOR AIDS DRUG ASSISTANCE PROGRAMS (ADAP) AND RYAN WHITE PART B PROGRAMS. PROGRAM ACTIVITIES INCLUDE A FOCUS ON ADAP CLINICAL QUALITY, AS WELL AS TA TO ADAPS ON VARIOUS ISSUES INCLUDING IMPLEMENTATION OF THE AFFORDABLE CARE ACT (ACA), INSURANCE PURCHASING, INTEGRATED PLANNING, FINANCIAL FORECASTING, IMPLEMENTING QUALITY MEASURES AND NEW DATA COLLECTION ACTIVITIES, DEVELOPING AND DISSEMINATING VARIOUS MATERIALS, AND IMPLEMENTING AND MONITORING DRUG PRICING AGREEMENTS. NASTAD HAS AN ONGOING PROJECT SUPPORTED BY CORPORATE DONORS TO MONITOR AND ASSESS THE STATUS OF STATE ADAPS AUTHORIZED UNDER PART B OF THE RYAN WHITE PROGRAM. IN ADDITION TO PRODUCING THE NATIONAL ADAP MONITORING PROJECT ANNUAL REPORT, THE PROGRAM PROVIDES TA TO STATE ADAPS REGARDING VARIOUS PROGRAMMATIC AND FISCAL ISSUES. NASTAD ALSO CONVENES AND SUPPORTS THE WORK OF AN ADAP CRISIS TASK FORCE, MADE UP OF STATE AIDS DIRECTORS AND ADAP COORDINATORS WORKING ON BEHALF OF ALL STATE HIV/AIDS PROGRAMS TO IMPROVE THE FISCAL STATUS OF STATE ADAP PROGRAMS. THIS PROGRAM IS SUPPORTED BY NASTAD'S MEMBERSHIP. NASTAD CONDUCTS A PREVENTION AND CARE TECHNICAL ASSISTANCE MEETING EACH YEAR FOR PREVENTION AND CARE, AND ADAP COORDINATORS AS WELL AS AIDS DIRECTORS. IT IS SUPPORTED THROUGH CORPORATE CONTRIBUTIONS SPECIFICALLY FOR THIS PURPOSE. NASTAD ALSO HAS ON ONGOING PROJECT SUPPORTED PRIMARILY BY CORPORATE DONORS AS WELL ANOTHER HRSA GRANTEE VIA A SUBCONTRACT TO PROVIDE TA TO HEALTH DEPARTMENTS AND TO MONITOR AND ASSESS THE STATUS OF IMPLEMENTATION OF THE ACA AT BOTH THE POLICY AND PROGRAMMATIC LEVELS.
VIRAL HEPATITIS: THROUGH A COOPERATIVE AGREEMENT WITH FUNDING FROM THE CDC'S DIVISION OF VIRAL HEPATITIS (THROUGH THE CSLTS FUNDING MECHANISM) NASTAD HAS A (VIRTUAL) TECHNICAL ASSISTANCE (TA) CENTER TO SUPPORT HEALTH DEPARTMENT HEPATITIS PROGRAMS WITH THE PREVENTION, SURVEILLANCE AND LABORATORY ACTIVITIES. THE PROGRAM INCLUDES SUPPORTING ALL OF THE CDC FUNDED HEPATITIS COORDINATORS WITH TAILORED TECHNICAL ASSISTANCE, IN PERSON AND VIRTUAL MEETINGS AND TA EVENTS, A REGULAR NEWSLETTER, AND AN ON-LINE DISTANCE LEARNING PLATFORM. ADDITIONALLY, THROUGH A COOPERATIVE AGREEMENT WITH THE CDC'S DIVISION OF VIRAL HEPATITIS, NASTAD CONVENES THE HEPATITIS TESTING PARTNERSHIP, A NATIONAL COALITION OF PUBLIC HEALTH AGENCIES, COMMUNITY BASED ORGANIZATIONS, HEALTH SYSTEMS AND OTHER KEY STAKEHOLDERS. COALITION MEMBERS SHARE LESSONS LEARNED, BEST PRACTICES AND STRATEGIES TO INCREASE SCREENING AND LINKAGE TO CARE FOR HEPATITIS C (HCV). NASTAD'S HEPATITIS PROGRAM ALSO INCLUDES PARTICIPATION AND LEADERSHIP IN THE NATIONAL VIRAL HEPATITIS ROUNDTABLE AND PROMOTION OF FEDERAL PROGRAMS THAT ADDRESS HEPATITIS A (HAV) AND B (HBV) VACCINE FOR HIGH RISK ADULTS, PREVENTION OF HCV, CHRONIC HBV AND HCV AND HIV HCV CO-INFECTION. THIS PROGRAM IS SUPPORTED BY BOTH THE MEMBERSHIP AND CORPORATE DONORS.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Natalie Cramer | SR. DIR., PREV./CARE PRO. & POL. | 40 | $158,741 |
Stephanie Porter | SR. DIR., HUMAN RESOURCES | 40 | $145,407 |
Amy Killelea | SENIOR DIR., HEALTH SYSTEMS & POLICY | 40 | $132,787 |
Michelle Batchelor | SR. DIR., GLOBAL PROG. (UNTIL 12/19) | 40 | $124,608 |
Isaiah Webster | DIR., CAPACITY BUILDING ASSISTANCE | 40 | $112,750 |
Stela Gurin | CONTROLLER, FIN./ADMIN (UNTIL 10/19) | 40 | $103,077 |
Virginie Carey | CFO (FROM 1/2020) | 40 | $0 |
Stephen Lee | EXECUTIVE DIRECTOR (FROM 2/2020) | 40 | $0 |
Peter Whiticar | BOARD MEMBER | 1 | $0 |
Jeremy Turner | BOARD MEMBER (FROM 6/2020) | 1 | $0 |
Laura Reeves | BOARD MEMBER | 1 | $0 |
Tracey Packer | BOARD MEMBER | 1 | $0 |
Randy Mayer | BOARD MEMBER | 1 | $0 |
Ali Mansaray | BOARD MEMBER | 1 | $0 |
William Lyons | BOARD MEMBER | 1 | $0 |
Martin Luta | BOARD MEMBER | 1 | $0 |
Dave Kern | BOARD MEMBER | 1 | $0 |
Sharon Jordan | BOARD MEMBER | 1 | $0 |
Susan Jones | BOARD MEMBER | 1 | $0 |
Andrew Gans | BOARD MEMBER | 1 | $0 |
Jan Fox | BOARD MEMBER (UNTIL 5/2020) | 1 | $0 |
Colin Flynn | BOARD MEMBER (FROM 6/2020) | 1 | $0 |
Dawn Fukuda | BOARD MEMBER | 1 | $0 |
Demetre Daskalakis | BOARD MEMBER | 1 | $0 |
Meredith Brantley | BOARD MEMBER | 1 | $0 |
Thomas Bertrand | BOARD MEMBER | 1 | $0 |
Michael Kharfen | SECRETARY-TREASURER | 4 | $0 |
Elizabeth Crutsinger-Perry | BD MBR TO VICE-CHAIR (TRANS. 5/2020) | 2 | $0 |
Shelley Lucas | BD MBR TO CHAIR-ELECT (TRANS. 5/20) | 3 | $0 |
Jacquelyn Clymore | IM PAST-CHAIR TO BD MBR (TRANS 5/20) | 2 | $0 |
Marlene Mcneese | CHAIR-ELECT TO CHAIR (TRANS. 5/2020) | 4 | $0 |
Johanne Morne | CHAIR TO IM PAST-CHAIR (TRANS. 5/20) | 4 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202101209349301215_public.xml